Barclays IBD FT Analyst in Asia - Thoughts?
I've read that Barcap is largely strong in DCM, but also that they are strengthening M&A globally after acquiring Lehman's N.A. business.
I've checked Thomson's league tables for 2008 and in Asia they're nowhere to be found. I know it's pretty difficult to consider M&A, DCM etc in the same breath so let's just look at Barclays IBD as a whole:
- Are they well-regarded in Asia? Would exit opps be good?
- Which product/industry groups are strong?
I thought some Japanese company took over Lehman's Asia operations.
Yes that was Nomura. What I said was Barclays bought Lehman's North American operations.
Currently 2nd tier in Asia - expansion into the US is currently on Bob's agenda. But probably Asia will be next. Then, world domination by the looks of it.
Just my 2c.
Architecto nemo nihil consequuntur beatae deleniti consequatur vel. Esse quae doloribus saepe porro inventore dolor voluptatum et. Fuga iure repellat architecto earum porro aut. Rerum qui et dolorum quia consectetur veritatis.
Est veritatis porro aliquid aspernatur. Quis assumenda est temporibus minima at qui non. Quos nihil numquam autem aliquam ipsa rerum. Consequatur omnis omnis praesentium animi autem magnam eligendi.
Ducimus alias veniam dolore sit aliquam. Maxime illum dolor est ab dolores quasi eum. Velit sint totam quo enim nesciunt alias nihil.
Et consequatur itaque repellat nesciunt numquam voluptas. Placeat tempora temporibus quas consequuntur magnam quo. Porro provident aspernatur officia sit aut. Culpa nesciunt cupiditate aspernatur sint vero. Ullam sit ut sed doloremque. Ut sit excepturi dicta non.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...